Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II inhibition

C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II inhibition

US Patent 10328050 · Granted Jun 25, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for treating patients having a genetic predisposition to dev2020
EGFR/NEDD9/TGF-β interactome and methods of use thereof for the identification o2019
EGFR/NEDD9/TGF-β interactome and methods of use thereof for the identification o2019
Method of treating MYC-amplified tumors with RNA-polymerase II inhibitors2018
Method of treating MYC-amplified tumors with RNA-polymerase II inhibitors2018
Methods of inhibiting proliferation of estrogen-independent cancer cells2017
Combination therapy based on SRC and aurora kinase inhibition for the treatment 2015
Combination therapy based on SRC and aurora kinase inhibition for the treatment 2015
Pyrrolidin-2-ones2015
Tetrahydro-isoquinolines2013
Combinations of ET-18-O-CH3and anti-cancer agents for the treatment of cancer2012
Tetrahydro-isoquinolin-1-ones for the treatment of cancer2012